EV Biologics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$1,267,134 and profit margin reached -2591%. Total operating expenses were $531,962.

Profit Margin

EV Biologics, Inc. (OTC:YECO): Profit margin
2013 42.48M 10.04M 23.66%
2014 44.45M 10.69M 24.05%
2015 46.23M 8.67M 18.77%
2016 42.64M -53.19M -124.73%
2017 9.47M -551.58K -5.82%
2019 0 -98.40K
2020 0 -98.96K
2021 118.9K -387.69K -326.07%
2022 0 -21.05M
2023 48.9K -1.26M -2591.28%

YECO Income Statement (2013 – 2023)

2023 2022 2021 2020 2019 2017 2016 2015 2014 2013
Revenue
Revenue
48.9K0118.9K009.47M42.64M46.23M44.45M42.48M
Cost of revenue
000007.93M26.16M29.36M27.50M26.78M
Gross profit
48.9K0118.9K001.53M16.47M16.86M16.95M15.69M
Operating exp.
Research and development
0000000000
Selling and marketing
00000624.67K451.92K634.39K930.47K869.29K
Total operating expenses
531.96K590.04K143.15K98.96K98.40K1.38M13.29M4.00M1.73M1.58M
Operating income
-483.06K-590.04K-24.26K-98.96K-98.4K52.39K3.28M12.85M15.21M14.11M
Other income (expenses), net
-784.07K-20.46M-363.43K-1-3-678.84K-53.12M-332.56K-1.28M-1.15M
Income before tax
-1.26M-21.05M-387.69K-98.96K-98.40K-523.98K-49.83M11.57M13.95M12.95M
Income tax expense
-167.89K00-206.29K027.59K3.35M2.89M3.25M2.90M
Net income
-1.26M-21.05M-387.69K-98.96K-98.40K-551.58K-53.19M8.67M10.69M10.04M
Earnings per share
Basic EPS
-0.12-2.91-0.05-0.01-0.010-22.35.46.945.24
Diluted EPS
-0.12-2.91-0.05-0.01-0.010-22.35.46.945.24